Skip to main content

Table 4 Intraoperative findings

From: The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage

Variables

Group A

Group B

Group C

Group A vs B

Group A vs C

Group B vs C

Intraoperative bleeding

12(75%)

2(12.5%)

1(6.25%)

P = 0.001

P = 0.000

P = 1

Endodiathermy

9(56.25%)

1(6.25%)

1(6.25%)

P = 0.006

P = 0.006

P = 1

Iatrogenic break

5(31.25%)

1(6.25%)

0(0%)

P = 0.172

P = 0.043

P = 1

Relaxing retinotomy

1(6.25%)

0(0%)

0(0%)

P = 1

P = 1

P = 1

Silicone-oil tamponade

9(56.25%)

2(12.5%)

2(12.5%)

P = 0.023

P = 0.023

P = 1

Balanced salt solution (BSS)

5(31.25%)

11(68.75%)

10(62.5%)

   

Sterile air

2(12.5%)

3(18.75%)

4(25%)

   

Surgical mean time (min)

110.625 ± 21.975

96.563 ± 16.705

86.25 ± 18.841

P = 0.05

P = 0.002

P = 0.112